Morphine decreases the function of primary human natural killer cells by both TLR4 and opioid receptor signaling
Authors:
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 83, 298-302
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Suppression of Human Natural Killer Cells by Different Classes of OpioidsAnesthesia & Analgesia, 2019
- Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicityHuman Immunology, 2017
- Clinically relevant concentrations of opioids for in vitro studiesJournal of Opioid Management, 2016
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug ReinforcementThe Journal of Neuroscience, 2012
- Morphine activates neuroinflammation in a manner parallel to endotoxinProceedings of the National Academy of Sciences, 2012
- Treatment of cancer painThe Lancet, 2011
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor MoleculesMolecular Pharmacology, 2011
- Evidence that opioids may have toll-like receptor 4 and MD-2 effectsBrain, Behavior, and Immunity, 2010
- LPS/TLR4 signal transduction pathwayCytokine, 2008
- The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase CJournal of Neuroscience, 1995